Echosens
Echosens develops and manufactures FibroScan, a non-invasive medical device used to assess liver stiffness and fat content through Vibration-Controlled Transient Elastography (VCTE). The technology supports healthcare professionals in the diagnosis, risk stratification, and monitoring of chronic liver diseases, including metabolic liver disease and cirrhosis. The company provides these diagnostic solutions to hospitals, clinics, and pharmaceutical researchers involved in clinical trials.
Healthtech
Medical Devices
Diagnostics
Biotechnology
Funding summary
- Total raised
- €30.0M
- Funding rounds
- 1
Investors in Echosens
Investors on record for Echosens. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Echosens?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors